Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Sirius Huang -- 7821 2022-09-29 01:33:22

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Clinical Trial. Encyclopedia. Available online: https://encyclopedia.pub/entry/28041 (accessed on 21 September 2026).
HandWiki. Clinical Trial. Encyclopedia. Available at: https://encyclopedia.pub/entry/28041. Accessed September 21, 2026.
HandWiki. "Clinical Trial" Encyclopedia, https://encyclopedia.pub/entry/28041 (accessed September 21, 2026).
HandWiki. (2022, September 29). Clinical Trial. In Encyclopedia. https://encyclopedia.pub/entry/28041
HandWiki. "Clinical Trial." Encyclopedia. Web. 29 September, 2022.
Clinical Trial
Edit

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted. Depending on product type and development stage, investigators initially enroll volunteers or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. Clinical trials can vary in size and cost, and they can involve a single research center or multiple centers, in one country or in multiple countries. Clinical study design aims to ensure the scientific validity and reproducibility of the results. Costs for clinical trials can range into the billions of dollars per approved drug. The sponsor may be a governmental organization or a pharmaceutical, biotechnology or medical device company. Certain functions necessary to the trial, such as monitoring and lab work, may be managed by an outsourced partner, such as a contract research organization or a central laboratory. Only 10 percent of all drugs started in human clinical trials become an approved drug.

human clinical trials clinical trials scientific validity

References

  1. FDA Page last updated 25 April 2014 FDA's Drug Review Process: Continued http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm289601.htm
  2. PhRMA. February 2007 Drug Discovery and Development http://www.phrma.org/sites/default/files/pdf/rd_brochure_022307.pdf
  3. Merck Manual. Last full review/revision October 2013 by Daniel A. Hussar, PhD Overview of Over-the-Counter Drugs http://www.merckmanuals.com/home/drugs/over-the-counter_drugs/overview_of_over-the-counter_drugs.html
  4. Avorn J. (2004). Powerful Medicines, pp. 129–33. Alfred A. Knopf.
  5. "Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review". JAMA 297 (11): 1233–40. March 2007. doi:10.1001/jama.297.11.1233. PMID 17374817.  https://dx.doi.org/10.1001%2Fjama.297.11.1233
  6. The regulatory authority in the USA is the Food and Drug Administration; in Canada, Health Canada; in the European Union, the European Medicines Agency; and in Japan, the Ministry of Health, Labour and Welfare
  7. "Medical Devices, Premarket Clinical Studies for Investigational Device Exemption". US Food and Drug Administration. 17 March 2017. https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketApprovalPMA/ucm050419.htm. 
  8. "Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial". JAMA 302 (14): 1535–42. October 2009. doi:10.1001/jama.2009.1426. PMID 19826022.  https://dx.doi.org/10.1001%2Fjama.2009.1426
  9. "Mechanical devices for urinary incontinence in women". The Cochrane Database of Systematic Reviews (12): CD001756. December 2014. doi:10.1002/14651858.CD001756.pub6. PMID 25517397. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0011167/. 
  10. "Randomized controlled trials of surgical interventions". Annals of Surgery 251 (3): 409–16. March 2010. doi:10.1097/SLA.0b013e3181cf863d. PMID 20142732.  https://dx.doi.org/10.1097%2FSLA.0b013e3181cf863d
  11. "Study design in evidence-based surgery: What is the role of case-control studies?". World Journal of Methodology 6 (1): 101–4. March 2016. doi:10.5662/wjm.v6.i1.101. PMID 27019801.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4804244
  12. Meinert, Curtis L.; Tonascia, Susan (1986). Clinical trials: design, conduct, and analysis. Oxford University Press, USA. p. 3. ISBN 978-0-19-503568-1. https://books.google.com/?id=i1oAxuE29MUC&pg=PA3&lpg=PA3. 
  13. Simon, Harvey B. (2002). The Harvard Medical School guide to men's health. New York: Free Press. p. 31. ISBN 978-0-684-87181-3. 
  14. Brown, Stephen R. (2003). Scurvy: How a Surgeon, a Mariner, and a Gentleman Solved the Greatest Medical Mystery of the Age of Sail. New York, NY: St. Martin's Press. ISBN 0-312-31391-8
  15. Rogers, Everett M. (1995). Diffusion of Innovations. New York, NY: The Free Press. ISBN 0-7432-2209-1. Page 7.
  16. Carlisle, Rodney (2004). Scientific American Inventions and Discoveries, John Wiley & Songs, Inc., New Jersey. p. 393. ISBN 0-471-24410-4.
  17. "James Lind: A Treatise of the Scurvy (1754)". 2001. http://www.bruzelius.info/Nautica/Medicine/Lind(1753).html. 
  18. Green, Stephanie; Crowley, John; Benedetti, Jacqueline; Smith, Angela (30 July 2002). Clinical Trials in Oncology, Second Edition. CRC Press. pp. 1–. ISBN 978-1-4200-3530-8. https://books.google.com/books?id=Zke8ocubNXAC&pg=PA1. 
  19. Gad, Shayne Cox (17 June 2009). Clinical Trials Handbook. John Wiley & Sons. pp. 118–. ISBN 978-0-470-46635-3. https://books.google.com/books?id=d8GxG0d9rpgC&pg=PA118. 
  20. "Frederick Akbar Mahomed". Hypertension 19 (2): 212–7. February 1992. doi:10.1161/01.HYP.19.2.212. PMID 1737655  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2308176
  21. Creswell, J.W. (2008). Educational research: Planning, conducting, and evaluating quantitative and qualitative research (3rd). Upper Saddle River, NJ: Prentice Hall. 2008, p. 300. ISBN 0-13-613550-1
  22. Hani (2009). "Replication study". http://www.experiment-resources.com/replication-study.html. 
  23. "Sir Geoffrey Marshall (1887-1982): respiratory physician, catalyst for anaesthesia development, doctor to both Prime Minister and King, and World War I Barge Commander". Journal of Medical Biography 19 (1): 10–4. February 2011. doi:10.1258/jmb.2010.010019. PMID 21350072.  https://dx.doi.org/10.1258%2Fjmb.2010.010019
  24. Pharmabiz.com, 19 May 2014, Mumbai ISCR releases Guide for clinical trial participants on International Clinical Trials Day (Accessed on 20 May 2014) http://www.pharmabiz.com/NewsDetails.aspx?aid=81931&sid=2
  25. "Glossary of Common Site Terms". clinicaltrials.gov. http://clinicaltrials.gov/ct2/info/glossary. 
  26. "EU Compassionate Use Programmes (CUPs): Regulatory Framework and Points to Consider before CUP Implementation". Pharm Med 24 (4): 223–229. 2010. doi:10.1007/BF03256820. http://adisonline.com/pharmaceuticalmedicine/Fulltext/2010/24040/EU_Compassionate_Use_Programmes__CUPs___Regulatory.4.aspx. 
  27. Brennan, Zachary (2013-06-05). "CROs Slowly Shifting to Adaptive Clinical Trial Designs". Outsourcing-pharma.com. http://www.outsourcing-pharma.com/Clinical-Development/CROs-Slowly-Shifting-to-Adaptive-Clinical-Trial-Designs. 
  28. "Adaptive Clinical Trials for Overcoming Research Challenges". News-medical.net. 2013-09-17. http://www.news-medical.net/whitepaper/20130916/Adaptive-Clinical-Trials-for-Overcoming-Research-Challenges.aspx. 
  29. Wang, Shirley S. (2013-12-30). "Health: Scientists Look to Improve Cost and Time of Drug Trials - WSJ.com". Online.wsj.com. https://www.wsj.com/news/articles/SB10001424052702304361604579290572010514840?KEYWORDS=adaptive+clinical+trial. 
  30. Huber, Peter W. (12 November 2013). The Cure in the Code: How 20th Century Law Is Undermining 21st Century Medicine. Basic Books. ISBN 978-0-465-06981-1. https://books.google.com/books?id=lU4TAAAAQBAJ. 
  31. The Lancet (July 2009). "Phase 0 trials: a platform for drug development?". Lancet 374 (9685): 176. doi:10.1016/S0140-6736(09)61309-X. PMID 19616703.  https://dx.doi.org/10.1016%2FS0140-6736%2809%2961309-X
  32. "Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations". JACC. Cardiovascular Interventions 1 (3): 211–7. June 2008. doi:10.1016/j.jcin.2008.01.008. PMID 19463302. http://www.sciencedirect.com/science/article/pii/S1936879808001702. 
  33. "Clinical Research Methodology 2: Observational Clinical Research". Anesthesia and Analgesia 121 (4): 1043–51. October 2015. doi:10.1213/ANE.0000000000000861. PMID 26378704. http://journals.lww.com/anesthesia-analgesia/Fulltext/2015/10000/Clinical_Research_Methodology_2___Observational.27.aspx. 
  34. "Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework". PLOS One 11 (3): e0150205. 2016. doi:10.1371/journal.pone.0150205. PMID 26978655.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4792418
  35. "Active Control / Active Comparator". http://www.statisticshowto.com/active-control-comparator/. 
  36. Young, Susan. "Foundation Medicine Joins Coalition Aiming to Shake Up Cancer Drug Trials | MIT Technology Review". Technologyreview.com. http://www.technologyreview.com/news/521496/can-genomics-blow-up-the-clinical-trial/. 
  37. ICH Guideline for Good Clinical Practice: Consolidated Guidance http://www.ich.org/LOB/media/MEDIA482.pdf
  38. "ICH Official web site : ICH". ich.org. http://www.ich.org/. 
  39. "Learn About Clinical Studies". clinicaltrials.gov. Archived from the original on 10 April 2012. https://web.archive.org/web/20120410030741/http://clinicaltrials.gov/ct2/info/understand. 
  40. Maloney, Dennis M (1984). Protection of Human Research Subjects: A Practical Guide to Federal Laws and Regulations. Boston, MA: Springer US. pp. 151. ISBN 9781461327035. 
  41. "FDA approval for use of medications in pregnancy: an uphill battle". Reviews in Obstetrics & Gynecology 4 (2): 39–41. 2011. PMID 22102925.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3218552
  42. "Frequently Asked Questions | University of Arizona Cancer Center". Azcc.arizona.edu. http://azcc.arizona.edu/patients/clinical-trials/faq. 
  43. "Pyromellitamide aggregates and their response to anion stimuli". Journal of the American Chemical Society 129 (22): 7155–62. June 2007. doi:10.1021/ja0713781. PMID 17497782.  https://dx.doi.org/10.1021%2Fja0713781
  44. "Impact of seasonality on conducting clinical studies in dermatology". Clinics in Dermatology 26 (5): 565–9. 2008. doi:10.1016/j.clindermatol.2008.01.016. PMID 18755376.  https://dx.doi.org/10.1016%2Fj.clindermatol.2008.01.016
  45. Khan, Yamin; Tilly, Sarah. "Seasonality: The Clinical Trial Manager's Logistical Challenge". Pharm-Olam International. http://www.pharm-olam.com/pdf/POI-Seasonality.pdf. 
  46. Yang, Z. J., et al. (2010). "Motivation for Health Information Seeking and Processing About Clinical Trial Enrollment." Health Communication 25(5): 423–436.
  47. "BIO to Use ViS Analytics to Streamline Pediatric Clinical Research - WSJ.com". Online.wsj.com. 2013-05-07. https://www.wsj.com/article/PR-CO-20130507-911627.html?mod=googlenews_wsj. 
  48. Life Sciences Strategy Group, "Clinical Trial Technology Utilization, Purchasing Preferences & Growth Outlook" Syndicated Publication, May 2009
  49. "Electronic Patient Reported Outcomes (ePRO) – Changing the Face of Clinical Trials". http://med-quest.org/electronic-patient-reported-outcomes-benefits/. 
  50. "Assembly Bill No. 2328". http://irb.ucsd.edu/ab_2328_bill_20020826_enrolled.pdf. 
  51. "Ethical dilemma for Ebola drug trials". Nature 515 (7526): 177–8. November 2014. doi:10.1038/515177a. PMID 25391940.  https://dx.doi.org/10.1038%2F515177a
  52. Pattinson, Shaun D. (2012). "Emergency research and the interests of participants" (in en). Medical Law International 12 (2): 121–141. doi:10.1177/0968533212465615.  https://dx.doi.org/10.1177%2F0968533212465615
  53. Moynihan, R. (2003). "Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement". British Medical Journal 326 (7400): 1193–1196. doi:10.1136/bmj.326.7400.1193. PMID 12775622.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1126054
  54. "Hogan & Hartson Update on Pharmaceutical Trial Registration" (PDF). 2008-03-03. http://www.hhlaw.com/files/Publication/edbf3429-125c-41c9-9442-b552e69b756c/Presentation/PublicationAttachment/972a9053-8c8d-46e4-ac96-ecf4892a8643/Pharma.pdf. 
  55. "Rise in Scientific Journal Retractions Prompts Calls for Reform". The New York Times. April 16, 2012. https://www.nytimes.com/2012/04/17/science/rise-in-scientific-journal-retractions-prompts-calls-for-reform.html. 
  56. "Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study". Current Medical Research and Opinion 27 (6): 1175–82. June 2011. doi:10.1185/03007995.2011.573546. PMID 21473670.  https://dx.doi.org/10.1185%2F03007995.2011.573546
  57. "Seeding trials: just say "no"". Annals of Internal Medicine 149 (4): 279–80. August 2008. doi:10.7326/0003-4819-149-4-200808190-00012. PMID 18711161. http://www.annals.org/cgi/pmidlookup?view=long&pmid=18711161. 
  58. "Development & Approval Process (Drugs)". U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/. 
  59. "Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors: FDA Inspections of Clinical Investigators". June 2010. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126553.pdf. 
  60. "Sponsorship, authorship and accountability". CMAJ 165 (6): 786–8. September 2001. PMID 11584570. PMC 81460. http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11584570. 
  61. "For Patients: Informed Consent for Clinical Trials". US Food and Drug Administration. 25 February 2016. https://www.fda.gov/forpatients/clinicaltrials/informedconsent/default.htm. 
  62. "Clinical trials have gone global: is this a good thing?". PLoS Medicine 9 (6): e1001228. 2012. doi:10.1371/journal.pmed.1001228. PMID 22719228.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3373653
  63. "India: Prime Destination for Unethical Clinical Trials". Common Dreams. http://www.commondreams.org/archive/2007/12/14/5838/. 
  64. Pmda.go.jp 独立行政法人 医薬品医療機器総合機構 (in Japanese) http://www.pmda.go.jp/ich/s/s1b_98_7_9e.pdf
  65. ICH http://www.ich.org/cache/compo/276-254-1.html
  66. "Management of Safety Information from Clinical Trials: Report of CIOMS Working Group VI". 2005. https://cioms.ch/shop/product/management-of-safety-information-from-clinical-trials-report-of-cioms-working-group-vi/. 
  67. "Investigational New Drug (IND) Application - Final Rule: Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans" (in en). Center for Drug Evaluation and Research. 2010-09-29. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm226358.htm. 
  68. "Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies Small Entity Compliance Guide". Food and Drug Administration =. December 2012. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM227351.pdf. 
  69. "Safety Assessment for IND Safety Reporting Guidance for Industry". Food and Drug Administration. December 2015. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM477584.pdf. 
  70. "Evidence Synthesis and Meta-Analysis: Report of CIOMS Working Group X". CIOMS Publications. 2016. https://cioms.ch/shop/product/evidence-synthesis-and-meta-analysis-report-of-cioms-working-group-x/. 
  71. Sertkaya, Aylin; Wong, Hui-Hsing; Jessup, Amber; Beleche, Trinidad (2016). "Key cost drivers of pharmaceutical clinical trials in the United States". Clinical Trials 13 (2): 117–126. doi:10.1177/1740774515625964. PMID 26908540.  https://dx.doi.org/10.1177%2F1740774515625964
  72. "Tax Credit for Testing Expenses for Drugs for Rare Diseases or Conditions". Food and Drug Administration. 17 April 2001. http://www.fda.gov/orphan/taxcred.htm. 
  73. "The Internet and clinical trials: background, online resources, examples and issues" (Free full text). Journal of Medical Internet Research 7 (1): e5. March 2005. doi:10.2196/jmir.7.1.e5. PMID 15829477. PMC 1550630. http://www.jmir.org/2005/1/e5/. 
  74. "Achieving Ethnic Diversity in Trial Recruitment". Pharm Med 25 (4): 215–222. 2011. doi:10.1007/BF03256863. http://adisonline.com/pharmaceuticalmedicine/Abstract/2011/25040/Achieving_Ethnic_Diversity_in_Trial_Recruitment.1.aspx. 
  75. "What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies". Trials 7: 9. April 2006. doi:10.1186/1745-6215-7-9. PMID 16603070.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1475627
  76. "Volunteering for a Clinical Trial". Boston, MA: CenterWatch. 2016. http://www.centerwatch.com/clinical-trials/volunteering.aspx. 
  77. "Parkinson's Disease Clinical Trials". Fox Trial Finder. http://www.foxtrialfinder.org. 
  78. "Medical Information on the Internet". Mlanet.org. http://www.mlanet.org/resources/hlth_tutorial/mod4c.html. 
  79. "Comparing decision making between cancer patients and the general population: thoughts, emotions, or social influence?". Journal of Health Communication 17 (4): 477–94. 2012. doi:10.1080/10810730.2011.635774. PMID 22376222.  https://dx.doi.org/10.1080%2F10810730.2011.635774
More
Upload a video for this entry
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 1.3K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 29 Sep 2022
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service